Gastrointest Interv 2018; 7(2): 85-87  https://doi.org/10.18528/gii180021
Percutaneous placement of self-expandable metallic stents in patients with obstructive jaundice due to hepatocellular carcinoma
Hyun Pyo Hong,* Kyungmin Park
Department of Radiology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
Department of Radiology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul 03181, Korea. E-mail address: summersonrad@naver.com (H.P. Hong). ORCID: https://orcid.org/0000-0003-1451-3141
Received: June 19, 2018; Revised: June 22, 2018; Accepted: June 22, 2018; Published online: July 31, 2018.
© Society of Gastrointestinal Intervention. All rights reserved.

cc This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
“Icteric type hepatoma” is a hepatocellular carcinoma (HCC) with tumor invasion to the bile duct (bile duct tumor thrombus, BDTT) causing obstructive jaundice. Effective and long-term decompression of the bile duct is essential for the palliative treatment for the patients. Percutaneous self-expandable metallic stent placement is a well-established treatment for palliating patients with an inoperative malignant biliary obstruction. This article reviews the treatment of percutaneous placement of self-expandable metallic stents for the management of obstructive jaundice caused by HCC.
Keywords: Bile ducts; Carcinoma, hepatocellular; Jaundice; Stents


This Article


Cited By Articles
  • CrossRef (0)

Services
Social Network Service

e-submission

Archives